Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Life Expectancy”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,351 records · Page 75Linked to original sources

An epidemiological study of Wolf-Hirschhorn syndrome: life expectancy and cause of mortality.

OBJECTIVE: Early research into Wolf-Hirschhorn syndrome (WHS) described a high mortality and no relationship between deletion size and phenotype. This may need to be revised in the light of improved cytogenetic resolution and medical care. We have collected epidemiological data to allow the calculation of birth incidence and mortality figures. In addition, we have investigated the possibility of a relationship between deletion size and mortality. METHOD: Information relating to past and present cases diagnosed in the UK was collected by multiple ascertainment. RESULTS: A total of 159 cases were collected. The status (alive or dead) was determined for 146, of whom 96 are alive, 37 had died, and 13 were detected on prenatal diagnostic tests. A minimum birth incidence of 1 in 95 896 was calculated. The crude infant mortality rate was 17% (23/132) and in the first two years of life the mortality rate was 21% (28/132). Cases with large de novo deletions (proximal to and including p15.2) were more likely to have died than those with smaller deletions (odds ratio=5.7, 95% CI=1.7-19.9) after adjusting for age. A comparison of survival curves for de novo deletions and translocations did not show a statistically significant difference (p=0.11). The median survival time for de novo deletions was 34+ years while for translocation cases it was 18+ years. CONCLUSIONS: The mortality rate is lower than previously reported. There is a statistically significant relationship between deletion size and overall risk of death in de novo deletion cases. The difference in survival curves between de novo deletions and translocations is not statistically significant.

Abnormalities, Multiple↗

[Life expectancy in the Plock area caused by lymphatic and erythrocyte line leukemia].

Among all specific environmental pollution the chemical compounds released in the oil refine process seem to hold the biggest interest. At Medical University of Warsaw we have been studying the influence of the Płock petroleum refinery plant pollution to citizens' health status for over 30 years. The high amount of hydrocarbons--including benzene--were presented in emission. One of the study objectives was to analyze death causes in Płock and Kutno and in the Płock area--according to environmental criteria. The population of the non-petrochemic polluted city Kutno was chosen as the control group. The previous analysis in 1984-1993 showed increased lymphatic or erythrocyte line leukaemia mortality in Płock population vs Kutno population. Similar situation was observed between the area of increased environmental petrochemical pollution and non-polluted area. In this article the Potential Years of Life Lost ratio was used to estimate the life deficiency as the measure of health needs due to mentioned neoplasms. Data indicate that the health needs are bigger than the mortality analysis has shown.

Air Pollutants↗

[Incorporation of work disability into the prolonged life expectancy process].

The various reasons of deficiency, as e.g., mortality, invalidity and notification of illness result in a decrease of the potential of work of the labour. Because of the mutual influence of these reasons, an isolated assessment of them only can be performed in a restricted manner. The loss of working years in male workers and clerks of the GDR (SV FDGB 1982) is calculated and assessed on the basis of the various reasons of deficiency.

Adult↗

The life-expectancy of persons with cerebral palsy.

Survival rates for persons with cerebral palsy were calculated using information from a population-based registry which has been collecting data since 1952. The 30-year survival rate approximates 87 per cent. Adverse factors affecting survival are the type of cerebral palsy (spastic quadriplegia having the worst prognosis), epilepsy and severe or profound mental retardation. The length of time over which the data were collected precludes estimating survival time beyond 30 years.

Adolescent↗

[Life expectancy and frequency of infarct after aorto-coronary bypass].

Survival rate and incidence of myocardial infarction after aortocoronary bypass operation in 274 patients are presented. Mortality was 5.1% within the first postoperative month and the 5-year-survival rate was 86%. There were 24 perioperative myocardial infarctions and another 21 infarctions over the next 5 years. Comparison of these data with the natural history of coronary heart disease suggests a possible prolongation of survival after bypass surgery. The incidence of myocardial infarction appears to be unchanged.

Angina Pectoris↗

The masculine gender role and its implications for the life expectancy of older men.

The lifespan of men is shorter than that of women. This study is an effort to identify some causal factors. Six dimensions of the masculine gender role examined in relation to certain stress-related disorders more prevalent among older men than among older women. These dimensions are "No Sissy Stuff"; "The Big Wheel"; "The Sturdy Oak"; "Give 'Em Hell"; homophobia; and sexual dysfunctioning. Specific problems of retirement are also discussed. Only in recent years have the roles of men been studied more closely. The results may offer positive implications for the lifespan of men.

Aged↗

[The life expectancy of patients radically treated for esophageal cancer at high altitude].

Postoperative lethality among patients who lived under high-altitude conditions proved to be higher than that among patients who lived at low altitudes before operations. Evidently, the terms of disadaptation at the preoperative period can influence the persons who lived under conditions of high-altitude hypoxia. It has been found that the cumulative 3-years survival rate of the esophageal cancer patients after the surgical treatment shows a two-fold rise as compared with that after the combined therapy, but the 5-years survival rate was almost the same.

Age Factors↗

[Study of life expectancy as the basis of determining the end result in health protection of the population].

The absence of a complex qualitative instrument for measuring population health hinders in assessing public health efficacy at the local level. There is introduced a principally new approach to the determination of health characteristics at the starting level proceeding from the exhausted viability. Impairments of viability are classified according to the cycles of human development, involving the intrauterine period, and according to medical causes corresponding to the specialization of treatment and preventive facilities. It is assumed to identify additional characteristics by means of correction factors.

Adult↗

[Sarcoidosis. Dependence of life expectancy on lung function, respiratory symptoms, roentgenologic stage and age at diagnosis and significance of extrapulmonary manifestations].

Patients with intrathoracic sarcoidosis have - during prolonged observation (27 years) - the same survival as the general population. A higher mortality from sarcoidosis as well as from diseases not related to sarcoidosis is found among persons who at the time of diagnosis of sarcoidosis had respiratory symptoms and a low FEV1, TLC and Tiffeneau. Our knowledge of the prognosis for extrapulmonary manifestations and their influence on survival is sporadic. Symptoms from heart and CNS have in studies of selected patients been connected with an elevated mortality.

Adolescent↗

Life expectancy after total hip arthroplasty.

The 6-year survival rate was investigated in 646 patients undergoing total hip arthroplasty for osteoarthritis, rheumatoid arthritis, or complications following femoral neck fracture between 1978 and 1982. A comparison of mortality was done between patients treated by osteosynthesis for fresh femoral neck fracture and a matched general population. The mortality was lower than that of the matched general population after total hip arthroplasty and even lower for patients treated for fresh femoral neck fracture. Patients undergoing total hip arthroplasty for osteoarthritis had the highest survival rate, followed by patients with rheumatoid arthritis and complications after femoral neck fractures.

Adult↗

Further evidence of preference reversals: choice, valuation and ranking over distributions of life expectancy.

Moving between choice and direct valuation procedures can cause substantial, systematic preference reversals, which is problematic because it leaves us unsure as to which procedure (if any) is 'best'. This article reports a study that tests whether using a ranking procedure to infer values rather than more conventional direct valuation can negate this phenomenon. The results suggest that the ranking procedure can render strict preference reversals both less substantial and less systematic. This could have important implications for the valuation of health outcomes, and in attempting to ascertain whether choice, valuation or ranking best uncovers people's preferences, similar tests in the context of more realistic health outcome descriptions are recommended.

Adolescent↗

[Total hip prosthesis: what is the life expectancy? Survey of 430 prostheses with a 10 to 12 year follow-up in 253 cases].

In 1987 we made a review of all total hip prostheses inserted at Hopital Henri Mondor in 1974-1975-1976. These were of the metal-polyethylene Charnley-Muller or Lagrange-Letournel type (430 prostheses inserted in 349 patients). 178 hips were reexamined and 177 were lost to follow up. 61 patients had died. Overall, good results were found in 65% of patients reviewed - 12.5% had been reoperated upon. Although the newer models of prostheses are full of promise, none has stood the test of 10 years of use.

Follow-Up Studies↗

Life expectancy and the value of early detection.

This paper presents a model of the benefits and costs of early detection of asymptomatic disease as they vary by age. The benefits of early detection tend toward zero as the risk of death from competing causes increases. Costs per detected case also decline with age, assuming that disease incidence rises with age, but are always strictly positive. On balance, there is always an age limit beyond which the costs associated with early detection outweigh the benefits. Application of the model to prostate cancer screening suggests that early detection above age 70 or so is not cost-effective.

Adult↗

Life expectancy in British Marfan syndrome populations.

A total of 206 patients with Marfan syndrome were ascertained throughout genetic clinics in Wales and Scotland during the period 1970-1990. There were 45 deaths representing 22% of the cohort. Mean age at death was 45.3+/-16.5 years. 50% median cumulative survival in the total cohort (n=206) was 53 years for males and 72 years for females. Multivariate analysis confirmed severity as the best independent indicator of survival. These findings and survival curves will assist in the counselling of British families and individuals with Marfan syndrome.

Adolescent↗

The impact of co-morbidity on life expectancy among men with localized prostate cancer.

PURPOSE: We evaluated 3 indexes used to assess patient co-morbidities to determine whether they could predict mortality among men with clinically localized prostate cancer. MATERIALS AND METHODS: We measured the impact of co-morbidity classifications on all cause mortality using a parametric proportional hazards model based on a retrospective cohort analysis. RESULTS: Each index tested is a highly significant predictor of mortality for patients dying of nonprostate cancer related causes after adjusting for age and Gleason score. CONCLUSIONS: Each co-morbidity index provides significant, independent predictive information concerning patient mortality beyond that provided by age, Gleason score and clinical stage alone.

Aged↗

[Chronic myeloid leukemia: multivariant analysis of initial findings regarding its effect on mean life expectancy].

Clinical signs, complete blood counts and bone marrow differential counts at the time of diagnosis were investigated in 75 consecutive patients with chronic myelogenous leukemia in a study of prognostic parameters. All patients were followed until death (62 patients) or for a mean follow-up time of 69 months (13 patients). Clinical signs and hematological values were analyzed by univariate and multivariate statistical methods. The only parameter relevant to mean survival time in multivariate analysis is the percentage of bone marrow myeloblasts at diagnosis. Patients with less than 5% myeloblasts at diagnosis had a mean survival time of 48 months compared with 16 months for those with greater than or equal to 5% (p less than 0.01).

Analysis of Variance↗

Gender differences in life expectancy free of impairment at older ages.

This article uses data from the United Kingdom Medical Research Council Cognitive Function and Ageing study (MRC CFAS) to analyze morbidity associated with three areas of impairment. We use cognitive status, functional status, and physical illness to examine differences in the proportion of time that older women and men will spend with co-morbidity. We also analyze differences among various impairments, and investigate the relationship between missing data and sex. Women have a larger burden of impairment than men, and, by including cognitive impairment together with functional impairment, a very large impairment burden is highlighted at all ages. Policy implications of the findings from the perspective of older women in the United Kingdom are discussed.

Activities of Daily Living↗

[Life expectancy of patients with circulatory disorders of the posterior eyeball segment].

Based on the method of person-years, the morality rate of 155 patients with circulatory disorders was calculated and compared with the death rate of an age-matched general population. No excess mortality was found among 53 patients with central retinal vein occlusion and among 58 patients with ischemic optic neuropathy. On the other hand, 44 patients with central retinal or branch artery occlusion showed a statistically significant increased mortality rate. Patients with arterial circulatory disorders were subdivided into hypertensives and normotensives; an increased mortality rate was seen only among patients with hypertension but not among patients with normal blood pressure. Hypertension is one of the main cardiovascular risk factors. The increased mortality risk among our patients with hypertension may be indicative of a progressive atherosclerosis.

Adult↗